Ikarian Capital’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,047
| Closed | -$21.6K | – | 96 |
|
|
2024
Q1 | $21.6K | Sell |
1,047
-367,083
| -100% | -$7.59M | ﹤0.01% | 78 |
|
|
2023
Q4 | $8.51M | Buy |
+368,130
| New | +$8.51M | 0.8% | 15 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 101 |
|
|
2022
Q2 | – | Sell |
-22,552
| Closed | -$274K | – | 119 |
|
|
2022
Q1 | $274K | Buy |
22,552
+1,125
| +5% | +$13.7K | 0.04% | 118 |
|
|
2021
Q4 | $262K | Sell |
21,427
-15,000
| -41% | -$183K | 0.04% | 118 |
|
|
2021
Q3 | $380K | Sell |
36,427
-83,708
| -70% | -$873K | 0.03% | 127 |
|
|
2021
Q2 | $1.08M | Hold |
120,135
| – | – | 0.09% | 108 |
|
|
2021
Q1 | $1.22M | Buy |
+120,135
| New | +$1.22M | 0.04% | 124 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 159 |
|